US regulatory status: approved.
pharma · Lupus Nephritis · Generalized Myasthenia Gravis · AUPH
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals drug portfolio — 10 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
1196 Hwy 3 South, Northfield, MN 55057, US HQ
2007 Founded
81 Employees
Public company Type
AUPH · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1196 Hwy 3 South, Northfield, MN 55057, US
- Founded
- 2007
- Employees
- 81
- Programs
- 14
- Drugs
- 10
- Patents
- 7
Aurinia Pharmaceuticals pipeline
Portfolio lens on 10 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Aurinia Pharmaceuticals drug portfolio — 10 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Aurinia Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Aurinia Pharmaceuticals in public FDA and regional records.
-
octreotide
Systemic hormonal preparations (H01)Systemic hormonal preparations (H01) compound in Aurinia Pharmaceuticals's portfolio. Mechanism: Somatostatin receptor agonist.
- Mechanism
- Somatostatin receptor agonist
-
Development asset linked to Aurinia Pharmaceuticals in public FDA and regional records.
-
US regulatory status: approved. Molecular target: 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
- Target
- 3-hydroxy-3-methylglutaryl-coenzyme A reductase
- Mechanism
- HMG-CoA reductase inhibitor
-
Development asset linked to Aurinia Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Aurinia Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Aurinia Pharmaceuticals in public FDA and regional records.
-
voclosporin
Antineoplastic and immunomodulating agents (L04)US regulatory status: approved. Molecular target: Protein phosphatase 3 catalytic subunit alpha.
- Target
- Protein phosphatase 3 catalytic subunit alpha
- Mechanism
- Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform inhibitor